These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 31097)
21. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study. Bai YM; Yu SC; Lin CC J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949 [TBL] [Abstract][Full Text] [Related]
22. Phenylethylamine-like properties of baclofen. Wolf ME; Keener S; Mathis P; Mosnaim AD Neuropsychobiology; 1983; 9(4):219-22. PubMed ID: 6646393 [TBL] [Abstract][Full Text] [Related]
23. Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies. Nair NP; Lal S; Schwartz G; Thavundayil JX Adv Biochem Psychopharmacol; 1980; 24():437-41. PubMed ID: 6773303 [TBL] [Abstract][Full Text] [Related]
24. The use of clonidine in the treatment of neuroleptic-induced tardive dyskinesia. Browne J; Silver H; Martin R; Hart R; Mergener M; Williams P J Clin Psychopharmacol; 1986 Apr; 6(2):88-92. PubMed ID: 2871058 [TBL] [Abstract][Full Text] [Related]
27. Propranolol in the treatment of tardive dyskinesia. Perényi A; Farkas A Biol Psychiatry; 1983 Mar; 18(3):391-4. PubMed ID: 6132627 [No Abstract] [Full Text] [Related]
28. Treatment of tardive dyskinesia with propranolol. Schrodt GR; Wright JH; Simpson R; Moore DP; Chase S J Clin Psychiatry; 1982 Aug; 43(8):328-31. PubMed ID: 6124534 [TBL] [Abstract][Full Text] [Related]
29. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study. Rondot P; Bathien N Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446 [No Abstract] [Full Text] [Related]
30. Effect of donepezil on tardive dyskinesia. Ogunmefun A; Hasnain M; Alam A; Osuala T; Regenold WT J Clin Psychopharmacol; 2009 Feb; 29(1):102-4. PubMed ID: 19142126 [No Abstract] [Full Text] [Related]
34. Clinical forms of severe tardive dyskinesia. Gardos G; Cole JO; Salomon M; Schniebolk S Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062 [TBL] [Abstract][Full Text] [Related]
35. [Tardive dyskinesia: etiology, clinical features and therapy]. Furer V; Lichtenberg P; Heresco-Levy U Harefuah; 2001 Mar; 140(3):248-52. PubMed ID: 11303354 [No Abstract] [Full Text] [Related]
36. [Tardive dyskinesia induced by neuroleptics. A review of the literature]. Diepart E; Cottereau MJ; Deniker P Encephale; 1979; 5(4):317-37. PubMed ID: 42528 [TBL] [Abstract][Full Text] [Related]
38. Do atypical antipsychotic agents cause tardive dyskinesia? Bailey KP J Psychosoc Nurs Ment Health Serv; 2004 Oct; 42(10):14-9. PubMed ID: 15540874 [No Abstract] [Full Text] [Related]
39. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients. Silver H; Geraisy N; Schwartz M J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856 [TBL] [Abstract][Full Text] [Related]
40. [Dimethylaminoethanol in the treatment of neuroleptic-induced tardive dyskinesia]. Lambert PA; Wolff P; de Maximy B; Ghenim A Ann Med Psychol (Paris); 1978 Apr; 136(4):625-9. PubMed ID: 31832 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]